Skip to main content
Jiangsu Nanfang Medical Co., Ltd. logo

Jiangsu Nanfang Medical Co., Ltd. — Investor Relations & Filings

Ticker · 603880 ISIN · CNE100002WH0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,144 across all filing types
Latest filing 2026-06-03 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603880

About Jiangsu Nanfang Medical Co., Ltd.

http://en.nfmedical.com.cn/

Jiangsu Nanfang Medical Co., Ltd. specializes in the research, development, and manufacturing of medical consumables and wound care products. The company's primary product portfolio includes adhesive bandages, surgical tapes, wound dressings, cooling patches, and comprehensive first aid kits. Utilizing advanced adhesive technology and skin-friendly materials, the firm provides solutions for clinical wound management and consumer healthcare. Its operations encompass the full production cycle from raw material processing to finished goods. The company serves a global market, supplying healthcare providers and retail sectors with products designed to meet international quality standards. Its focus remains on enhancing wound healing efficiency and patient comfort through continuous innovation in medical dressing materials and application methods.

Recent filings

Filing Released Lang Actions
南卫股份关于控股股东部分股份解除质押及再质押的公告
Regulatory Filings Classification · 80% confidence The document is a Chinese stock exchange announcement detailing the controlling shareholder’s partial release of pledged shares and re-pledging of shares. It does not contain financial results, board changes, dividends, M&A, or proxy materials; instead, it is a regulatory disclosure of a shareholder collateral transaction. There is no specific category for share pledges, so it falls under the general Regulatory Filings (RNS) category.
2026-06-03 Chinese
南卫股份对关于控股子公司减资的公告
Share Issue/Capital Change Classification · 88% confidence The document is a public announcement by Jiangsu Southern Weicai Medical Pharmaceuticals Co. about a board-approved reduction of registered capital in its controlling subsidiary, including details of share capital amounts before and after the reduction. This is a corporate capital change event. According to the definitions, announcements of capital changes (e.g., capital reductions, share issues, stock splits) fall under Share Issue/Capital Change (SHA).
2026-05-28 Chinese
南卫股份2025年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document is a formal announcement of resolutions passed at the company’s 2025 Annual General Meeting, detailing the vote counts and percentages for each proposal. This matches the definition for a Declaration of Voting Results (DVA), not the report itself or any other category.
2026-05-20 Chinese
江苏南方卫材医药股份有限公司2025年年度股东会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 85% confidence The document is a legal opinion (“法律意见书”) issued by a law firm on the convening, procedures, and formal voting results of the company’s 2025 annual shareholders’ meeting. It includes detailed official vote counts for multiple agenda items. Under the taxonomy, a filing that provides official shareholder vote results at a general meeting is classified as Declaration of Voting Results & Voting Rights Announcements (Code: DVA).
2026-05-20 Chinese
南卫股份关于召开2025年年度暨2026年第一季度业绩暨现金分红说明会的公告
Investor Presentation Classification · 90% confidence The document is an announcement about a scheduled investor meeting to discuss the 2025 annual and 2026 first quarter performance and cash dividends. It provides details about the meeting time, location, participation method, and contact information. The document does not contain actual financial statements or detailed financial analysis but rather invites investors to an interactive session where company management will answer questions. The document length is short (1348 characters) and it is clearly an announcement of an upcoming event rather than the event transcript or a financial report. Therefore, it fits best as an Investor Presentation (IP) since it is a detailed presentation for investors focusing on financials, strategy, and market position, conducted via a live interactive session.
2026-05-08 Chinese
南卫股份2025年第一次临时股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2025 first extraordinary shareholders' meeting of Jiangsu Southern Medical Materials Pharmaceutical Co., Ltd. It includes information about the meeting date, location, attendance, voting results on various proposals including amendments to the company charter and board elections, and legal witness statements. The content focuses on board and shareholder meeting decisions, particularly the election of board members and amendments to company bylaws. This matches the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it reports official voting outcomes from a shareholders' meeting. The document length is 2417 characters, which is sufficient to contain detailed voting results rather than just an announcement of a report publication. Therefore, the classification is DVA with high confidence.
2025-12-25 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.